Patents by Inventor Zufang Huang

Zufang Huang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10935495
    Abstract: The present invention discloses a detection and analysis method for urine-modified nucleoside based on a surface-enhanced resonance Raman spectroscopy technology. In the method, a tumor marker modified nucleoside in the urine of a normal person and a cancer patient is extracted through the specificity of borophenylic acid gel; Au colloid is taken as an enhancing substrate to detect SERRS signals; and statistical analysis is conducted by using PLS-DA algorithms to establish a diagnosis and identification model for the SERRS of the urine-modified nucleoside. The model is used to discriminate that the to-be-detected urine-modified nucleoside belongs to the normal person or the cancer patient. After PLS-DA, the surface-enhanced resonance Raman spectroscopy data of the urine-modified nucleoside of the present invention has specificity of 96.9%, sensitivity of 98.2% and accuracy of 97.6%.
    Type: Grant
    Filed: September 18, 2016
    Date of Patent: March 2, 2021
    Assignee: Fujian Normal University
    Inventors: Shangyuan Feng, Zuci Zheng, Qiwen Wang, Lan Wang, Duo Lin, Cuncheng Weng, Zufang Huang, Yongzeng Li, Rong Chen
  • Publication number: 20200326285
    Abstract: The present invention discloses a detection and analysis method for urine-modified nucleoside based on a surface-enhanced resonance Raman spectroscopy technology. In the method, a tumor marker modified nucleoside in the urine of a normal person and a cancer patient is extracted through the specificity of borophenylic acid gel; Au colloid is taken as an enhancing substrate to detect SERRS signals; and statistical analysis is conducted by using PLS-DA algorithms to establish a diagnosis and identification model for the SERRS of the urine-modified nucleoside. The model is used to discriminate that the to-be-detected urine-modified nucleoside belongs to the normal person or the cancer patient. After PLS-DA, the surface-enhanced resonance Raman spectroscopy data of the urine-modified nucleoside of the present invention has specificity of 96.9%, sensitivity of 98.2% and accuracy of 97.6%.
    Type: Application
    Filed: September 18, 2016
    Publication date: October 15, 2020
    Applicant: Fujian Normal University
    Inventors: Shangyuan FENG, Zuci ZHENG, Qiwen WANG, Lan WANG, Duo LIN, Cuncheng WENG, Zufang HUANG, Yongzeng LI, Rong CHEN
  • Patent number: 8525980
    Abstract: This invention provides a body fluid detection method by using surface enhanced Raman spectroscopy. In this method, some biological macromolecules in body fluid samples could be separated with membrane electrophoresis technique firstly. Next, samples are cut off along with the substrates and touched with glacial acetic acid. Transparent colloid formed while incubating. Then add enhancing substrates and continue to incubate and stir. When solid impurities precipitated, stop incubating and stand for layering. In the end, take upper layer resulted to be tested using SERS detection method and build SERS database. This invention successfully eliminated disturbance of other complex components on the SERS detection of protein, DNA and RNA. High quality SERS spectrum obtained is beneficial to the analysis and process of SERS spectrum. Thus body fluid can be differentiated by comparing body fluid SERS spectrum belonging to the healthy people and patients.
    Type: Grant
    Filed: June 21, 2010
    Date of Patent: September 3, 2013
    Inventors: Juqiang Lin, Rong Chen, Shangyuan Feng, Yongzeng Li, Guannan Chen, Zufang Huang, Min Cheng, Yun Yu, Haishan Zeng
  • Publication number: 20120062885
    Abstract: This invention provides a body fluid detection method by using surface enhanced Raman spectroscopy. In this method, some biological macromolecules in body fluid samples could be separated with membrane electrophoresis technique firstly. Next, samples are cut off along with the substrates and touched with glacial acetic acid. Transparent colloid formed while incubating. Then add enhancing substrates and continue to incubate and stir. When solid impurities precipitated, stop incubating and stand for layering. In the end, take upper layer resulted to be tested using SERS detection method and build SERS database. This invention successfully eliminated disturbance of other complex components on the SERS detection of protein, DNA and RNA. High quality SERS spectrum obtained is beneficial to the analysis and process of SERS spectrum. Thus body fluid can be differentiated by comparing body fluid SERS spectrum belonging to the healthy people and patients.
    Type: Application
    Filed: June 21, 2010
    Publication date: March 15, 2012
    Inventors: Juqiang Lin, Rong Chen, Shangyuan Feng, Yongzeng Li, Guannan Chen, Zufang Huang, Min Cheng, Yun Yu, Haishan Zeng